Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Bima Sakti Pertiwi Tbk. (PAMG) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Bima Sakti Pertiwi Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Bima Sakti Pertiwi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Bima Sakti Pertiwi Tbk. trades at Rp52 (market cap 162.5B, 2.57M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Bima Sakti Pertiwi Tbk. is more actively traded (2.57M versus 129.6K). Which is the better fit depends on your goals.

DGNSPAMG
Market Cap
308B162.5B
Volume
129.6K2.57M
Lot
1.3K25.72K
Turnover
28.71M130.93M
Average Price
221.5450.9
Value
28.71M130.93M
Indicative Equilibrium Price
23052
Indicative Equilibrium Volume
11023

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
PAMG
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Bima Sakti Pertiwi Tbk.

PT Bima Sakti Pertiwi Tbk (the Company) was established based on the Notarial Deed of Raden Minarno Hardjokoesoemo, S.H., Deputy Notary in Tanjungpinang, No. 30, dated April 28, 1980.

Read more on PAMG